Association of methylenetetrahydrofolate reductase T677 allele with early development of chronic allograft nephropathy

Clinical Biochemistry

Volumn 37, Issue 10, 2004, Pages 919-924

  Viklický, Ondřej ^a   Hubáček, Jaroslav A ^a   Kvasnička, Jan ^b   Matl, Ivo ^a   Voska, Luděk ^a   Skibová, Jelena ^a   Teplan, Vladimír ^a   Vítko, Štefan ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

CD14; Chronic allograft nephropathy; Gene polymorphism; IL 6; MTHFR

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CD14 ANTIGEN; INTERLEUKIN 6;

ADULT; ALLELE; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA;

ALLELES; ANTIGENS, CD14; CHRONIC DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GRAFT VS HOST DISEASE; HUMANS; INTERLEUKIN-6; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, GENETIC; PROTEINURIA; TRANSPLANTATION, HOMOLOGOUS;

EID: 4444300236     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2004.05.022     Document Type: Article

References (34)

1. Ponticelli C., Villa M., Cesana B., Montagnino G., Tarantino A. Risk factors for late kidney allograft failure. Kidney Int. 62:2002;1848-1854
2. Tullius S.G., Tilney N.L. Both alloantigen-dependent and-independent factors influence chronic allograft rejection. Transplantation. 59:1995;313-318
3. Rush D., Nickerson P., Jeffery J. Protocol biopsies in the management of renal allograft recipients. Curr. Opin. Nephrol. Hypertens. 9:2000;615-619
4. Kasiske B.L. Risk factors for accelerated atherosclerosis in renal transplant recipients. Am. J. Med. 84:1988;985-992
5. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340:1999;115-126
6. Suthanthiran M. The importance of genetic polymorphisms in renal transplantation. Curr. Opin. Urol. 10:2000;71-75
7. Cortese C., Motti C. MTHFR gene polymorphism, homocysteine and cardiovascular disease. Public Health Nutr. 4:2001;493-497
8. Bostom A.G., Lathrop L. Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int. 52:1997;10-20
9. Marcucci R., Fedi S., Brunelli T., et al. High cysteine levels in renal transplant recipients: relationship with hyperhomocysteinemia and 5,10-MTHFR polymorphism. Transplantation. 71:2001;746-751
10. Fodinger M., Wolfl G., Fischer G., et al. Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients. Kidney Int. 55:1999;1072-1080
11. Elstein E., Huan C., Fitchett M., Cantarovitch M., Marpole D. C677T gene mutation in methyltetrahydrofolate reductase as a risk factor for cardiac allograft vasculopathy. Transplant Proc. 31:1999;99
12. Rattazzi M., Puato M., Faggin E., Bertipaglia B., Zambon A., Pauletto P. C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders? J. Hypertens. 21:2003;1787-1803
13. Greisenegger S., Endler G., Haering D., et al. The (-174) G/C polymorphism in the interleukin-6 gene is associated with the severity of acute cerebrovascular events. Thromb. Res. 110:2003;181-186
14. Losito A., Kalidas K., Santoni S., Jeffery S. Association of interleukin-6-174G/C promoter polymorphism with hypertension and left ventricular hypertrophy in dialysis patients. Kidney Int. 64:2003;616-622
15. Lu K.C., Jaramillo A., Lecha R.L., et al. T. Interleukin-6 and interferon-gamma gene polymorphisms in the development of bronchiolitis obliterans syndrome after lung transplantation. Transplantation. 74:2002;1297-1302
16. Antal-Szalmás P. Evaluation of CD14 in host defence. Eur. J. Clin. Invest. 30:2000;167-179
17. Baldini M., Lohman I.C., Halonen M., et al. A Polymorphism* in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am. J. Respir. Cell Mol. Biol. 20:1999;976-983
18. Hubacek J.A., Rothe G., Pit'ha J., et al. C(-260)->T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation. 99:1999;3218-3220
19. Racusen L.C., Solez K., Colvin R.B., et al. The Banff 97 working classification of renal allograft pathology. Kidney Int. 55:1999;713-723
20. Benes P., Kankova K., Muzik J., et al. Methylenetetrahydrofolate reductase polymorphism, type II diabetes mellitus, coronary artery disease, and essential hypertension in the Czech population. Mol. Genet. Metab. 73:2001;188-195
21. Day I.N., Humphries S.E. Electrophoresis for genotyping: microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose. Anal. Biochem. 222:1994;389-395
22. Nankivell B.J., Borrows R.J., Fung C.L., et al. The natural history of chronic allograft nephropathy. N. Engl. J. Med. 349:2003;2326-2333
23. Viklicky O., Hubacek J.A., Pitha J., et al. ACE gene polymorphism and long-term renal graft function. Clin. Biochem. 34:2001;89-92
24. Marder B., Schroppel B., Murphy B. Genetic variability and transplantation. Curr. Opin. Urol. 13:2003;81-89
25. Krieger N.R., Becker B.N., Heisey D.M., et al. Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts. Transplantation. 75:2003;1677-1682
26. Radermacher J., Mengel M., Ellis S., et al. The renal arterial resistance index and renal allograft survival. N. Engl. J. Med. 349:2003;115-124
27. Manns B.J., Burgess E.D., Hyndman M.E., et al. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease. Am. J. Kidney Dis. 34:1999;669-677
28. Szabo A.J., Tulassay T., Melegh B., et al. Hyperhomocysteinaemia and MTHFR C677T gene polymorphism in renal transplant recipients. Arch. Dis. Child. 85:2001;47-49
29. Ducloux D., Motte G., Challier B., Gibey R., Chalopin J.M. Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study. J. Am. Soc. Nephrol. 11:2000;134-137
30. Fodinger M., Buchmayer H., Heinz G., et al. Effect of MTHFR 1298A->C and MTHFR 677C->T genotypes on total homocysteine, folate, and vitamin B(12) plasma concentrations in kidney graft recipients. J. Am. Soc. Nephrol. 11:2000;1918-1925
31. Hagen W., Fodinger M., Heinz G., Buchmayer H., Horl W.H., Sunder-Plassmann G. Effect of MTHFR genotypes and hyperhomocysteinemia on patient and graft survival in kidney transplant recipients. Kidney Int. Suppl. 78:2001;S253-S257
32. Liangos O., Kreutz R., Beige J., Offermann G., Distler A., Sharma A.M. Methylenetetrahydrofolate-reductase gene C677T variant and kidney-transplant survival. Nephrol. Dial. Transplant. 13:1998;2351-2354
33. Kosokabe T., Okumura K., Sone T., et al. Relation of a common methylenetetrahydrofolate reductase mutation and plasma homocysteine with intimal hyperplasia after coronary stenting. Circulation. 103:2001;2048-2054
34. Tilney N.L., Guttmann R.D. Effects of initial ischemia/reperfusion injury on the transplanted kidney. Transplantation. 64:1997;945-947